Ofatumumab and Bendamustine for Previously Treated Chronic Lymphocytic Leukemia (CLL)
Status:
Terminated
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and effectiveness of the combination of
bendamustine and ofatumumab in subjects with relapsed/refractory chronic lymphocytic leukemia
and small cell lymphoma. All subjects enrolled on this study will receive both drugs by
intravenous (IV) infusion.